clinical trials

What Stops Patient Engagement in Clinical Trials

Last week I was invited to speak at Bayer’s Headquarters during their Annual Patient Engagement Meetup. This year I was attending a lot of other similar events thanks to our collaboration with different companies like Boehringer Ingelheim, Merck, Novartis, etc. And the last one really reminded me of: What Stops Patient Engagement in Clinical Research? …

What Stops Patient Engagement in Clinical Trials Read More »

How to move to virtual clinical trials during Covid-19 (Part 3)

Part 1 | Part 2 Engage with participants Far from creating a sense of remoteness, virtual trials can prevent patients from feeling isolated by creating more timely and personalized touchpoints. Fortunately, existing technologies have paved the way to more engaging interactions with patients and assessment of their overall health and safety. When going virtual, ensure …

How to move to virtual clinical trials during Covid-19 (Part 3) Read More »

How to move to virtual clinical trials during Covid-19 (Part 2)

Return to Part 1 Protect participants and study staff Consider minimizing exposure for study participants and reducing in-person appointments that would require the participant to engage in non-essential travel. Many elements of the study visits can be supported with virtual technologies such as remote monitoring. Patients that are chronically or critically ill and at risk …

How to move to virtual clinical trials during Covid-19 (Part 2) Read More »

How to move to virtual clinical trials during Covid-19 (Part 1)

The majority of clinical trials worldwide are conducted in hospitals or major research institutions, mainly in the bigger cities. This prevents people who live hours away from having the opportunity to take part. Accessibility creates problems for people whose condition doesn’t let them travel or drive or those who are working or having family responsibilities. …

How to move to virtual clinical trials during Covid-19 (Part 1) Read More »

Guidance on the Management of Clinical Trials during COVID-19: How Countries respond

2020 began with a surprise for many people, industries and governments. The coronavirus outbreak turned the world upside down and became a global threat the likes of which we hadn’t experienced for ages. Unfortunately, the clinical research industry was also impacted severely mostly due to the social distancing measures recommended by national and global organisations …

Guidance on the Management of Clinical Trials during COVID-19: How Countries respond Read More »

3 Factors CROs Consider Sponsors Rarely Think Of

Clinical Research Organizations (CRO) are the go-to partner for helping biotech and pharma companies to research, evaluate and launch their new brilliant idea of a novel compound or medical device. And in fact, the CRO market has been growing in the last few years and is expected to reach $44bln by 2021. You can see …

3 Factors CROs Consider Sponsors Rarely Think Of Read More »

Data sources in Feasibility for clinical trials | Part 2

In my last article about Feasibility, data sources are defined so that you can recognise the best ones and choose which ones to use. To summarise, no matter what data sources you use they should be: Accurate Meaningful All-encompassing   If you want to learn more about this, you can read my previous article: Today …

Data sources in Feasibility for clinical trials | Part 2 Read More »

Data sources in Feasibility for clinical trials? | Part 1

Feasibility for clinical trials is all about finding the right sources of data, being able to analyse them and then make decisions for country selection, sites and investigators, as well as patient recruitment strategies. It sounds simple and yet, when it comes to execution it’s very complicated. Therefore feasibility specialists have a lot of questions …

Data sources in Feasibility for clinical trials? | Part 1 Read More »

How to measure patient enrollment (on budget and on time)

There are many questions when planning a clinical trial. But one of those questions is the main one: How many patients can we enroll? And the answer is everything but straightforward or easy to provide. Yet, answering this one question could mean the world to a biotech startup that just raised its funding and gives …

How to measure patient enrollment (on budget and on time) Read More »

Global Clinical Operations Director’s insights from 2008 and top lessons that apply during COVID-19

Estrella Garcia is with Almirall for 27 years and is currently their Global Clinical Operations Director. She was with the pharma company during the last financial crisis and went through some really hard times for the company. She shares with Maya Zlatanova, CEO of FindMeCure Ltd., the lessons she learned and that helped them not …

Global Clinical Operations Director’s insights from 2008 and top lessons that apply during COVID-19 Read More »